Advanstar Communications' healthcare and pharmaceutical science brands team up for 'Cardiometabolic Disorders and Weight: Action for Outcomes' initiative

Article

Advanstar Communications' "Cardiometabolic Disorders and Weight: Action for Outcomes" initiative brings together comprehensive tools and information from our Web portal ModernMedicine.com, our 15 healthcare brands, and two of our pharmaceutical science publications.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
1 expert in this video
1 expert in this video
1 expert in this video
1 expert in this video
ODs reflect on their time in Minneapolis, Minnesota, citing continuing education, tech updates, and networking opportunities as valued takeaways from the meeting.
Nora Lee Cothran, OD, FAAO, discussed the importance of optometrists addressing mental health with patients in their chair.
Nora Lee Cothran, OD, FAAO, moderated an Innovation Hub panel that featured 3 companies, giving insights into what's to come in the optometric industry.
Selina McGee, OD, shares what she wants to see in future State of Dry Eye surveys and how this year's results will affect her patient care.
Marc Bloomenstein, OD, FAAO, is a clinical investigator in the trials and overviews the transformative potential of LNZ100.
Shawn Hobbs, OD, previews the annual NOA convention, which takes place in Columbus, Ohio, from July 10 to 12, 2025.
Related Content
Laboratory desk Image credit: AdobeStock/Shutter2U

Monthly pipeline update: A July news roundup

Jordana Joy, Associate Editor
August 2nd 2025
Article
The Neural Network: Exploring The Role of Neuromodulation in Dry Eye Disease Management

The Neural Network: Exploring The Role of Neuromodulation in Dry Eye Disease Management

August 2nd 2025
Podcast
Woman administering eye drop Image credit: AdobeStock/megaflopp

Alcon commercially launches Tryptyr (acoltremon ophthalmic solution) 0.003% for signs and symptoms of DED in the US

Jordana Joy, Associate Editor
August 2nd 2025
Article
Neurotrophic Keratitis: Multidisciplinary Approaches to Enhance Patient Outcomes

Neurotrophic Keratitis: Multidisciplinary Approaches to Enhance Patient Outcomes

August 2nd 2025
Podcast
FDA approved graphic Image courtesy of MJH Life Sciences

FDA approved LENZ Therapeutics’ VIZZ for the treatment of presbyopia

Emily Kaiser Maharjan, Assistant Managing Editor
August 2nd 2025
Article
EyePoint completes enrollment of LUGANO and LUCIA trials - Image credit: ©JHDT Productions—stock.adobe.com

EyePoint completes enrollment of LUGANO and LUCIA trials

Kassi Filkins, Editor
August 2nd 2025
Article
© 2025 MJH Life Sciences

All rights reserved.